开放期刊系统

3种血细胞亚型对缺血性脑卒中评估的研究进展

杰 张(承德医学院附属医院神经内科,中国)
亮 赵(承德医学院附属医院神经内科,中国)

摘要

在全世界范围内,卒中为死亡第二大病因,而在中国,卒中已成为第一位死亡病因,其中急性缺血性卒中(急性脑梗死AIS)为卒中类型中最常见类型,占脑卒中比例中69.6%~70.8%,并且我们发现卒中发生的年龄层逐渐扩大,向年轻化发展,脑卒中的发作、进展为患者个人、家庭、社会带来沉重负担。越来越多研究指出,炎症反应与缺血性脑损伤密切相关,并推动病情的发展,在此背景下为了进一步指导临床医师诊疗决策的选取,大量血细胞亚型及新型炎症指标对卒中的评估被投入进广泛研究中,论文总结了近年来MHR、NPAR、SII与缺血性卒中的研究现状,希望为疾病的诊断、治疗带来新的思路,进而减轻患者个人、家庭及社会因AIS所致的沉重负担。

关键词

MHR;NPAR;SII;急性缺血性卒中

全文:

PDF (English)

参考

蒙科帆,李长清.进展性卒中的研究进展[J].中国实用神经疾病杂志,2022,25(8):1017-1022.

中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.

IADECOLA C, ANRATHER J. The immunology of stroke: from mechanisms to translation[J]. Nature medicine,2011,17(7):796-808.

王瑶,谢敏杰.调节性T细胞与脑卒中的免疫反应[J].神经损伤与功能重建,2019,14(12):626-629.

郝峻巍.免疫炎症与脑卒中的基础及临床研究[J].神经病学与神经康复学杂志,2019,15(1):32-35.

方芳,舒怡,肖志杰.卒中相关性肺炎的临床研究进展[J].中华危重病急救医学,2019,31(11):1429-1434.

Cyclic adenosine monophosphate in acute ischemic stroke: some to update, more to explore[J]. Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology,2020,413.

Rawlinson C, Jenkins S, Thei L, et al. Post-Ischaemic Immunological Response in the Brain: Targeting Microglia in Ischaemic Stroke Therapy[J]. Brain Sci, 2020;10(3):159.

Wang HY, Shi WR, Yi X, et al. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort[J]. Lipids Health Dis, 2019 May 30;18(1):127.

Sharma D, Aravind S, Joseph S, et al. The Role of Monocyte to High-density Lipoprotein Cholesterol Ratio in Predicting the Severity of Acute Ischemic Stroke and its Association with the NIHSS[J]. J Assoc Physicians India, 2023 Aug;71(8):11-12.

Bi X, Liu X, Cheng J. Monocyte to High-Density Lipoprotein Ratio Is Associated With Early Neurological Deterioration in Acute Isolated Pontine Infarction[J]. Front Neurol, 2021 Jun 28;12:678884.

Wang Y, Cheng Y, Song Q, et al. The association between monocyte to high-density lipoprotein ratio and hemorrhagic transformation in patients with acute ischemic stroke[J]. Aging (Albany NY), 2020 Feb 5;12(3):2498-2506.

Yang N, Hu L, Han Y. The association between monocyte to high-density lipoprotein cholesterol ratio and clinical prognosis of acute ischemic stroke after intravenous thrombolysis therapy[J]. Medicine (Baltimore), 2023 Oct 6;102(40):e35338.

Meng D, Li Y, Ju T, et al. Low MHR Is Associated with Hemorrhagic Transformation in Acute Large Artery Atherosclerosis Ischemic Stroke Patients with Intravenous Thrombolysis[J]. Clin Appl Thromb Hemost, 2023 Jan-Dec;29:10760296231167849.

Oh SW, Yi HJ, Lee DH, et al. Prognostic Significance of Various Inflammation-Based Scores in Patients with Mechanical Thrombectomy for Acute Ischemic Stroke[J]. World Neurosurg, 2020 Sep;141:710-717.

Li X, Wu F, Jiang C, et al. Novel peripheral blood cell ratios: Effective 3-month post-mechanical thrombectomy prognostic biomarkers for acute ischemic stroke patients[J]. J Clin Neurosci, 2021 Jul;89:56-64.

Bolayir A, Gokce SF, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients[J]. Neurol Neurochir Pol, 2018 Mar;52(2):150-155.

Mao S, Hu Y, Zheng X, et al. Correlation Analysis of Neutrophil/Albumin Ratio and Leukocyte Count/Albumin Ratio with Ischemic Stroke Severity[J]. Cardiol Cardiovasc Med, 2023;7(1):32-38.

Cui T, Wang C, Zhu Q, et al. Association between neutrophil percentage-to-albumin ratio and 3-month functional outcome in acute ischemic stroke patients with reperfusion therapy[J]. Front Neurol, 2022 Sep 13;13:898226.

Yang D, Niu C, Li P, et al. Study of the neutrophil percentage-to-albumin ratio as a biomarker for predicting recurrence of first-episode ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2023 Nov 15;33(1):107485.

Zhang H, Wu T, Tian X, et al. High Neutrophil Percentage-To-Albumin Ratio Can Predict Occurrence of Stroke-Associated Infection[J]. Front Neurol, 2021 Sep 8;12:705790.

Chen Z, Xie D, Li Y, et al. Neutrophil Albumin Ratio is Associated with All-Cause Mortality in Stroke Patients: A Retrospective Database Study[J]. Int J Gen Med, 2022 (4);15:1-9.

Agard TA, Hass R, Cavrak ME, et al. Neutrophil lymphocyte ratio (NLR) and systemic immune inflammatory index (SII) for the differential diagnosis of CT-negative mild acute ischemic stroke and transient ischemic attack[J]. Int J Neurosci, 2023 Jan 31:1-8.

Huang L. Increased Systemic Immune-Inflammation Index Predicts Disease Severity and Functional Outcome in Acute Ischemic Stroke Patients[J]. Neurologist, 2023,28(1):32-38.

Yi HJ, Sung JH, Lee DH. Systemic Inflammation Response Index and Systemic Immune-Inflammation Index Are Associated with Clinical Outcomes in Patients Treated with Mechanical Thrombectomy for Large Artery Occlusion[J]. World Neurosurg, 2021(153):282-289.

Ji Y, Xu X, Wu K, et al. Prognosis of Ischemic Stroke Patients Undergoing Endovascular Thrombectomy is Influenced by Systemic Inflammatory Index Through Malignant Brain Edema[J]. Clin Interv Aging, 2022 Jul 2;17:1001-1012.

Li WC, Zhou YX, Zhu G, et al. Systemic immune inflammatory index is an independent predictor for the requirement of decompressive craniectomy in large artery occlusion acute ischemic stroke patients after mechanical thrombectomy[J]. Front Neurol, 2022 Sep 27;13:945437.

Yang Y, Cui T, Bai X, et al. Association Between Systemic Immune-Inflammation Index and Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment[J]. Curr Neurovasc Res, 2022;19(1):83-91.

Zhao J, Dong L, Hui S, et al. Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA[J]. Clin Appl Thromb Hemost, 2023 Jan-Dec;29:10760296231198042.

Ma F, Li L, Xu L, et al. The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis[J]. J Neuroinflammation, 2023 Sep 30;20(1):220.

Topcuoglu MA, Pektezel MY, Yilmaz E, et al. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility[J]. Angiology, 2021 Mar;72(3):279-284.

Bao Y, Wang L, Du C, et al. Association between Systemic Immune Inflammation Index and Cognitive Impairment after Acute Ischemic Stroke[J]. Brain Sci, 2023 Mar 9;13(3):464.

Adiguzel A, Arsava EM, Topcuoglu MA. Temporal course of peripheral inflammation markers and indexes following acute ischemic stroke: prediction of mortality, functional outcome, and stroke-associated pneumonia[J]. Neurol Res, 2022 Mar;44(3):224-231.

Hu X, Liang J, Hao W, et al. Prognostic value of inflammatory markers for in-hospital mortality in intensive care patients with acute ischemic stroke: a retrospective observational study based on MIMIC-IV[J]. Front Neurol, 2023 Jun 8;14:1174711.

Han J, Yang L, Lou Z, et al. Association between Systemic Immune-Inflammation Index and Systemic Inflammation Response Index and Outcomes of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis[J]. Ann Indian Acad Neurol, 2023 Sep-Oct;26(5):655-662.



DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i1.15588

Refbacks

  • 当前没有refback。
版权所有(c)2024 杰 张, 亮 赵 Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
  • :+65-62233778 QQ:2249355960 :contact@s-p.sg